These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2747971)

  • 21. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
    Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of prickly pear (Opuntia robusta) on glucose- and lipid-metabolism in non-diabetics with hyperlipidemia--a pilot study.
    Wolfram RM; Kritz H; Efthimiou Y; Stomatopoulos J; Sinzinger H
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):840-6. PubMed ID: 12503475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of glibenclamide on lipid metabolism in non-insulin-dependent diabetic patients].
    Ratzmann KP; Schimke E; Herrmann C; Borngräber G; Meusel K
    Z Gesamte Inn Med; 1988 Mar; 43(5):122-4. PubMed ID: 3133890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutritional status and plasma lipids in diabetic subjects.
    Ristić V; Raden S; Ristić M; Manojlović D
    Acta Med Iugosl; 1989; 43(3):197-203. PubMed ID: 2741721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma lipids in reflex sympathetic dystrophy. A study apropos of 90 cases].
    Eulry F; Chevalier X; Crozes P; Lechevalier D; Magnin J; Prudat M; Patoz P; Larget-Piet B
    Rev Rhum Mal Osteoartic; 1992 Nov; 59(11):721-7. PubMed ID: 1306590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Persisting hyperlipidemias as risk factors of diabetic macroangiopathy].
    Vogelberg KH; Meurers G
    Klin Wochenschr; 1986 Jun; 64(11):506-11. PubMed ID: 3523028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The coagulation picture and plasma clearance capacity in atherosclerotic diabetics].
    Miti L; Sprovieri G; Breschi L; Civerchia D; Foglia A
    Arch Sci Med (Torino); 1978; 135(2):187-96. PubMed ID: 356822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia.
    Sijbrands EJ; Smelt AH
    J Clin Epidemiol; 2000 Oct; 53(10):1020-4. PubMed ID: 11027934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alcohol, blood lipids and advanced age].
    Casale G; Guaita A
    Minerva Med; 1978 Mar; 69(15):1015-8. PubMed ID: 662131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dyslipemia in type-2 diabetes. A risk factor for macroangiopathy?].
    Lara Suriñach N; Franch Nadal J; Morató Griera J; Egido Polo A; Puig Galy J; Castillejo Medina J
    Aten Primaria; 1996 Jun; 18(1):3-8. PubMed ID: 8768534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of thrombocytes and plasma for the regulation of hemostasis in type II diabetics].
    Sinzinger H; Fitscha P
    Vasa; 1985; 14(2):121-4. PubMed ID: 4013489
    [No Abstract]   [Full Text] [Related]  

  • 35. Altered metabolism of acetaldehyde in blood is not a specific marker of diabetic macroangiopathy.
    Ohlin H; Jerntorp P; Brattström L; Almér LO; Israelsson B
    Diabetes Res; 1991 Feb; 16(2):75-9. PubMed ID: 1817808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.
    Gamba G; Solerte SB; Grignani G; Pacchiarini L; Montani N; Ferrari E
    Blut; 1988 Jun; 56(6):257-60. PubMed ID: 3382760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-I in type 2 (non-insulin-dependent) diabetics with myocardial infarction and without macroangiopathy.
    Järveläinen H; Rönnemaa T; Kallio V
    Atherosclerosis; 1986 Mar; 59(3):335-40. PubMed ID: 3964354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Severe hypertriglyceridemia without organ complications in an alcoholic non-diabetic patient].
    Maioli M; Pes GM; Piga G; Puddu L; Masala S; Errigo A; Tolu F; Secchi G; Delitala G
    Clin Ter; 2009; 160(3):217-21. PubMed ID: 19756325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigations on the lipid metabolism in patients with chronic alcoholism (author's transl)].
    Kinalska I; Gabryelewicz A
    Przegl Lek; 1978; 35(4-5):440-1. PubMed ID: 693992
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transitory hyperlipemia and hypercholesterolemia in alcoholics].
    MERIAN E; FINCKER L
    Strasb Med; 1962 Feb; 13():80-7. PubMed ID: 14472799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.